ADH1B and cancer: We analyzed the correlation of TOP2A and ADH1B expression levels in LUAD and LUSC cases with several parameters such as patients' gender, age, individual cancer stage, histological subtype, nodal metastasis status, and TP53 mutation status, in the UALCAN database, respectively.